Doctor profile · Federal record
Dr. David Jager, M.D.
Gastroenterology Physician (CMS: Gastroenterology) · Rockville, MD
- NPI 1689846842
- Accepts Medicare
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
14955 Shady Grove RD, Suite 150
Rockville, MD 208508700
(301) 340-3252
Credentials & registration
- NPI registered
- March 2008 — 18 yrs on file
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- Maryland #D0066888
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689846842. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,851
Distinct HCPCS
10
Medicare allowed
$259,212
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3380 |
Injection, vedolizumab, 1 mg | 4,800 | 12 | $20 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,190 | 11 | $33 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 191 | 173 | $95 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 166 | 133 | $140 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 121 | 121 | $176 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 101 | 98 | $111 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 81 | 81 | $121 | |
G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk | 52 | 52 | $202 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 38 | 38 | $183 | |
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 35 | 35 | $278 |
In context: peer comparison
Among 13 peers in Rockville Gastroenterology Physician, average services per provider: 222. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$682
Transactions
36
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | 11 | $180.76 | |
| Takeda Pharmaceuticals U.S.A., INC. | 8 | $132.37 | |
| Daiichi Sankyo INC. | 2 | $57.52 | |
| Celgene Corporation | 3 | $56.58 | |
| Abbvie INC. | 2 | $43.04 | |
| Qol Medical, LLC | 1 | $40.53 | |
| Ironwood Pharmaceuticals, INC | 2 | $39.98 | |
| Pfizer INC. | 2 | $37.63 | |
| Phathom Pharmaceuticals, INC. | 2 | $28.44 | |
| Ferring Pharmaceuticals INC. | 1 | $25.10 | |
| Janssen Biotech, INC. | 1 | $21.91 | |
| Regeneron Healthcare Solutions, INC. | 1 | $17.97 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
489
Patients
185
Total drug cost
$109,369
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Pantoprazole Sodium | Generic | 133 | 41 | $2,517 |
| Famotidine | Generic | 70 | 22 | $1,308 |
| Clenpiq (Sod Picosulf/Mag Ox/Citric Ac) | Brand | 68 | 67 | $11,957 |
| Omeprazole | Generic | 65 | 23 | $1,162 |
| Dexlansoprazole Dr (Dexlansoprazole) | Brand | 38 | 11 | $20,919 |
| Linzess (Linaclotide) | Brand | 37 | 0 | $22,761 |
| Creon (Lipase/Protease/Amylase) | Brand | 25 | 0 | $26,983 |
| Mesalamine | Generic | 21 | 0 | $14,871 |
| Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,Mag Sulfates) | Brand | 21 | 21 | $1,768 |
| Mesalamine Dr (Mesalamine) | Brand | 11 | 0 | $5,122 |
Frequently asked questions
What is Dr. David Jager's medical specialty?
Dr. David Jager practices Gastroenterology Physician in Rockville, MD.
Where does Dr. David Jager practice?
Dr. David Jager practices at 14955 Shady Grove RD, Rockville, MD 208508700. Office phone: 3013403252.
What is Dr. David Jager's NPI?
Dr. David Jager's National Provider Identifier (NPI) is 1689846842, issued by NPPES.
Does Dr. David Jager accept Medicare assignment?
Yes. Dr. David Jager accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Jager commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.